The global IV and Oral Iron Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for IV and Oral Iron Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IV and Oral Iron Drugs.

Report Scope

The IV and Oral Iron Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IV and Oral Iron Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the IV and Oral Iron Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of IV and Oral Iron Drugs Market Report

Report Metric	Details
Report Name	IV and Oral Iron Drugs Market
CAGR	5%
Segment by Type	Oral Iron Drug IVIron Drugs
Segment by Application	Nephrology OBGYN Surgeries Gastroenterology Oncology Heart failure (HF)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Daiichi Sankyo Company, Vifor Pharma, Akebia Therapeutics, Allergan, AMAG Pharmaceuticals, AOP Orphan Pharmaceuticals, Pharmacosmos, Sanofi, Shield Therapeutics, AZAD Pharma, Cirondrugs, MEDICE, Pfizer, Salveo Lifecare, Sunny Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IV and Oral Iron Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the IV and Oral Iron Drugs Market report?

Ans: The main players in the IV and Oral Iron Drugs Market are Daiichi Sankyo Company, Vifor Pharma, Akebia Therapeutics, Allergan, AMAG Pharmaceuticals, AOP Orphan Pharmaceuticals, Pharmacosmos, Sanofi, Shield Therapeutics, AZAD Pharma, Cirondrugs, MEDICE, Pfizer, Salveo Lifecare, Sunny Pharmaceutical

What are the Application segmentation covered in the IV and Oral Iron Drugs Market report?

Ans: The Applications covered in the IV and Oral Iron Drugs Market report are Nephrology, OBGYN, Surgeries, Gastroenterology, Oncology, Heart failure (HF)

What are the Type segmentation covered in the IV and Oral Iron Drugs Market report?

Ans: The Types covered in the IV and Oral Iron Drugs Market report are Oral Iron Drug, IVIron Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global IV and Oral Iron Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Oral Iron Drug

1.2.3 IVIron Drugs

1.3 Market by Application

1.3.1 Global IV and Oral Iron Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Nephrology

1.3.3 OBGYN

1.3.4 Surgeries

1.3.5 Gastroenterology

1.3.6 Oncology

1.3.7 Heart failure (HF)

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global IV and Oral Iron Drugs Market Perspective (2019-2030)

2.2 IV and Oral Iron Drugs Growth Trends by Region

2.2.1 Global IV and Oral Iron Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 IV and Oral Iron Drugs Historic Market Size by Region (2019-2024)

2.2.3 IV and Oral Iron Drugs Forecasted Market Size by Region (2025-2030)

2.3 IV and Oral Iron Drugs Market Dynamics

2.3.1 IV and Oral Iron Drugs Industry Trends

2.3.2 IV and Oral Iron Drugs Market Drivers

2.3.3 IV and Oral Iron Drugs Market Challenges

2.3.4 IV and Oral Iron Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top IV and Oral Iron Drugs Players by Revenue

3.1.1 Global Top IV and Oral Iron Drugs Players by Revenue (2019-2024)

3.1.2 Global IV and Oral Iron Drugs Revenue Market Share by Players (2019-2024)

3.2 Global IV and Oral Iron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by IV and Oral Iron Drugs Revenue

3.4 Global IV and Oral Iron Drugs Market Concentration Ratio

3.4.1 Global IV and Oral Iron Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by IV and Oral Iron Drugs Revenue in 2023

3.5 IV and Oral Iron Drugs Key Players Head office and Area Served

3.6 Key Players IV and Oral Iron Drugs Product Solution and Service

3.7 Date of Enter into IV and Oral Iron Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 IV and Oral Iron Drugs Breakdown Data by Type

4.1 Global IV and Oral Iron Drugs Historic Market Size by Type (2019-2024)

4.2 Global IV and Oral Iron Drugs Forecasted Market Size by Type (2025-2030)

5 IV and Oral Iron Drugs Breakdown Data by Application

5.1 Global IV and Oral Iron Drugs Historic Market Size by Application (2019-2024)

5.2 Global IV and Oral Iron Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America IV and Oral Iron Drugs Market Size (2019-2030)

6.2 North America IV and Oral Iron Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America IV and Oral Iron Drugs Market Size by Country (2019-2024)

6.4 North America IV and Oral Iron Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe IV and Oral Iron Drugs Market Size (2019-2030)

7.2 Europe IV and Oral Iron Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe IV and Oral Iron Drugs Market Size by Country (2019-2024)

7.4 Europe IV and Oral Iron Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific IV and Oral Iron Drugs Market Size (2019-2030)

8.2 Asia-Pacific IV and Oral Iron Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific IV and Oral Iron Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific IV and Oral Iron Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America IV and Oral Iron Drugs Market Size (2019-2030)

9.2 Latin America IV and Oral Iron Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America IV and Oral Iron Drugs Market Size by Country (2019-2024)

9.4 Latin America IV and Oral Iron Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa IV and Oral Iron Drugs Market Size (2019-2030)

10.2 Middle East & Africa IV and Oral Iron Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa IV and Oral Iron Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa IV and Oral Iron Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Daiichi Sankyo Company

11.1.1 Daiichi Sankyo Company Company Detail

11.1.2 Daiichi Sankyo Company Business Overview

11.1.3 Daiichi Sankyo Company IV and Oral Iron Drugs Introduction

11.1.4 Daiichi Sankyo Company Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.1.5 Daiichi Sankyo Company Recent Development

11.2 Vifor Pharma

11.2.1 Vifor Pharma Company Detail

11.2.2 Vifor Pharma Business Overview

11.2.3 Vifor Pharma IV and Oral Iron Drugs Introduction

11.2.4 Vifor Pharma Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.2.5 Vifor Pharma Recent Development

11.3 Akebia Therapeutics

11.3.1 Akebia Therapeutics Company Detail

11.3.2 Akebia Therapeutics Business Overview

11.3.3 Akebia Therapeutics IV and Oral Iron Drugs Introduction

11.3.4 Akebia Therapeutics Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.3.5 Akebia Therapeutics Recent Development

11.4 Allergan

11.4.1 Allergan Company Detail

11.4.2 Allergan Business Overview

11.4.3 Allergan IV and Oral Iron Drugs Introduction

11.4.4 Allergan Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.4.5 Allergan Recent Development

11.5 AMAG Pharmaceuticals

11.5.1 AMAG Pharmaceuticals Company Detail

11.5.2 AMAG Pharmaceuticals Business Overview

11.5.3 AMAG Pharmaceuticals IV and Oral Iron Drugs Introduction

11.5.4 AMAG Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.5.5 AMAG Pharmaceuticals Recent Development

11.6 AOP Orphan Pharmaceuticals

11.6.1 AOP Orphan Pharmaceuticals Company Detail

11.6.2 AOP Orphan Pharmaceuticals Business Overview

11.6.3 AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Introduction

11.6.4 AOP Orphan Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.6.5 AOP Orphan Pharmaceuticals Recent Development

11.7 Pharmacosmos

11.7.1 Pharmacosmos Company Detail

11.7.2 Pharmacosmos Business Overview

11.7.3 Pharmacosmos IV and Oral Iron Drugs Introduction

11.7.4 Pharmacosmos Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.7.5 Pharmacosmos Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Detail

11.8.2 Sanofi Business Overview

11.8.3 Sanofi IV and Oral Iron Drugs Introduction

11.8.4 Sanofi Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.8.5 Sanofi Recent Development

11.9 Shield Therapeutics

11.9.1 Shield Therapeutics Company Detail

11.9.2 Shield Therapeutics Business Overview

11.9.3 Shield Therapeutics IV and Oral Iron Drugs Introduction

11.9.4 Shield Therapeutics Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.9.5 Shield Therapeutics Recent Development

11.10 AZAD Pharma

11.10.1 AZAD Pharma Company Detail

11.10.2 AZAD Pharma Business Overview

11.10.3 AZAD Pharma IV and Oral Iron Drugs Introduction

11.10.4 AZAD Pharma Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.10.5 AZAD Pharma Recent Development

11.11 Cirondrugs

11.11.1 Cirondrugs Company Detail

11.11.2 Cirondrugs Business Overview

11.11.3 Cirondrugs IV and Oral Iron Drugs Introduction

11.11.4 Cirondrugs Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.11.5 Cirondrugs Recent Development

11.12 MEDICE

11.12.1 MEDICE Company Detail

11.12.2 MEDICE Business Overview

11.12.3 MEDICE IV and Oral Iron Drugs Introduction

11.12.4 MEDICE Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.12.5 MEDICE Recent Development

11.13 Pfizer

11.13.1 Pfizer Company Detail

11.13.2 Pfizer Business Overview

11.13.3 Pfizer IV and Oral Iron Drugs Introduction

11.13.4 Pfizer Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.13.5 Pfizer Recent Development

11.14 Salveo Lifecare

11.14.1 Salveo Lifecare Company Detail

11.14.2 Salveo Lifecare Business Overview

11.14.3 Salveo Lifecare IV and Oral Iron Drugs Introduction

11.14.4 Salveo Lifecare Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.14.5 Salveo Lifecare Recent Development

11.15 Sunny Pharmaceutical

11.15.1 Sunny Pharmaceutical Company Detail

11.15.2 Sunny Pharmaceutical Business Overview

11.15.3 Sunny Pharmaceutical IV and Oral Iron Drugs Introduction

11.15.4 Sunny Pharmaceutical Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.15.5 Sunny Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Daiichi Sankyo Company

AOP Orphan Pharmaceuticals

List of Tables

Table 1. Global IV and Oral Iron Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Oral Iron Drug

Table 3. Key Players of IVIron Drugs

Table 4. Global IV and Oral Iron Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global IV and Oral Iron Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global IV and Oral Iron Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global IV and Oral Iron Drugs Market Share by Region (2019-2024)

Table 8. Global IV and Oral Iron Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global IV and Oral Iron Drugs Market Share by Region (2025-2030)

Table 10. IV and Oral Iron Drugs Market Trends

Table 11. IV and Oral Iron Drugs Market Drivers

Table 12. IV and Oral Iron Drugs Market Challenges

Table 13. IV and Oral Iron Drugs Market Restraints

Table 14. Global IV and Oral Iron Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global IV and Oral Iron Drugs Market Share by Players (2019-2024)

Table 16. Global Top IV and Oral Iron Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IV and Oral Iron Drugs as of 2023)

Table 17. Ranking of Global Top IV and Oral Iron Drugs Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by IV and Oral Iron Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players IV and Oral Iron Drugs Product Solution and Service

Table 21. Date of Enter into IV and Oral Iron Drugs Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global IV and Oral Iron Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global IV and Oral Iron Drugs Revenue Market Share by Type (2019-2024)

Table 25. Global IV and Oral Iron Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global IV and Oral Iron Drugs Revenue Market Share by Type (2025-2030)

Table 27. Global IV and Oral Iron Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global IV and Oral Iron Drugs Revenue Market Share by Application (2019-2024)

Table 29. Global IV and Oral Iron Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global IV and Oral Iron Drugs Revenue Market Share by Application (2025-2030)

Table 31. North America IV and Oral Iron Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America IV and Oral Iron Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America IV and Oral Iron Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe IV and Oral Iron Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe IV and Oral Iron Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe IV and Oral Iron Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific IV and Oral Iron Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific IV and Oral Iron Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific IV and Oral Iron Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America IV and Oral Iron Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America IV and Oral Iron Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America IV and Oral Iron Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa IV and Oral Iron Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa IV and Oral Iron Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa IV and Oral Iron Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 46. Daiichi Sankyo Company Company Detail

Table 47. Daiichi Sankyo Company Business Overview

Table 48. Daiichi Sankyo Company IV and Oral Iron Drugs Product

Table 49. Daiichi Sankyo Company Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 50. Daiichi Sankyo Company Recent Development

Table 51. Vifor Pharma Company Detail

Table 52. Vifor Pharma Business Overview

Table 53. Vifor Pharma IV and Oral Iron Drugs Product

Table 54. Vifor Pharma Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 55. Vifor Pharma Recent Development

Table 56. Akebia Therapeutics Company Detail

Table 57. Akebia Therapeutics Business Overview

Table 58. Akebia Therapeutics IV and Oral Iron Drugs Product

Table 59. Akebia Therapeutics Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 60. Akebia Therapeutics Recent Development

Table 61. Allergan Company Detail

Table 62. Allergan Business Overview

Table 63. Allergan IV and Oral Iron Drugs Product

Table 64. Allergan Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 65. Allergan Recent Development

Table 66. AMAG Pharmaceuticals Company Detail

Table 67. AMAG Pharmaceuticals Business Overview

Table 68. AMAG Pharmaceuticals IV and Oral Iron Drugs Product

Table 69. AMAG Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 70. AMAG Pharmaceuticals Recent Development

Table 71. AOP Orphan Pharmaceuticals Company Detail

Table 72. AOP Orphan Pharmaceuticals Business Overview

Table 73. AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Product

Table 74. AOP Orphan Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 75. AOP Orphan Pharmaceuticals Recent Development

Table 76. Pharmacosmos Company Detail

Table 77. Pharmacosmos Business Overview

Table 78. Pharmacosmos IV and Oral Iron Drugs Product

Table 79. Pharmacosmos Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 80. Pharmacosmos Recent Development

Table 81. Sanofi Company Detail

Table 82. Sanofi Business Overview

Table 83. Sanofi IV and Oral Iron Drugs Product

Table 84. Sanofi Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 85. Sanofi Recent Development

Table 86. Shield Therapeutics Company Detail

Table 87. Shield Therapeutics Business Overview

Table 88. Shield Therapeutics IV and Oral Iron Drugs Product

Table 89. Shield Therapeutics Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 90. Shield Therapeutics Recent Development

Table 91. AZAD Pharma Company Detail

Table 92. AZAD Pharma Business Overview

Table 93. AZAD Pharma IV and Oral Iron Drugs Product

Table 94. AZAD Pharma Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 95. AZAD Pharma Recent Development

Table 96. Cirondrugs Company Detail

Table 97. Cirondrugs Business Overview

Table 98. Cirondrugs IV and Oral Iron Drugs Product

Table 99. Cirondrugs Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 100. Cirondrugs Recent Development

Table 101. MEDICE Company Detail

Table 102. MEDICE Business Overview

Table 103. MEDICE IV and Oral Iron Drugs Product

Table 104. MEDICE Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 105. MEDICE Recent Development

Table 106. Pfizer Company Detail

Table 107. Pfizer Business Overview

Table 108. Pfizer IV and Oral Iron Drugs Product

Table 109. Pfizer Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 110. Pfizer Recent Development

Table 111. Salveo Lifecare Company Detail

Table 112. Salveo Lifecare Business Overview

Table 113. Salveo Lifecare IV and Oral Iron Drugs Product

Table 114. Salveo Lifecare Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 115. Salveo Lifecare Recent Development

Table 116. Sunny Pharmaceutical Company Detail

Table 117. Sunny Pharmaceutical Business Overview

Table 118. Sunny Pharmaceutical IV and Oral Iron Drugs Product

Table 119. Sunny Pharmaceutical Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 120. Sunny Pharmaceutical Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Global IV and Oral Iron Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global IV and Oral Iron Drugs Market Share by Type: 2023 VS 2030

Figure 3. Oral Iron Drug Features

Figure 4. IVIron Drugs Features

Figure 5. Global IV and Oral Iron Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global IV and Oral Iron Drugs Market Share by Application: 2023 VS 2030

Figure 7. Nephrology Case Studies

Figure 8. OBGYN Case Studies

Figure 9. Surgeries Case Studies

Figure 10. Gastroenterology Case Studies

Figure 11. Oncology Case Studies

Figure 12. Heart failure (HF) Case Studies

Figure 13. IV and Oral Iron Drugs Report Years Considered

Figure 14. Global IV and Oral Iron Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global IV and Oral Iron Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global IV and Oral Iron Drugs Market Share by Region: 2023 VS 2030

Figure 17. Global IV and Oral Iron Drugs Market Share by Players in 2023

Figure 18. Global Top IV and Oral Iron Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IV and Oral Iron Drugs as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by IV and Oral Iron Drugs Revenue in 2023

Figure 20. North America IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America IV and Oral Iron Drugs Market Share by Country (2019-2030)

Figure 22. United States IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe IV and Oral Iron Drugs Market Share by Country (2019-2030)

Figure 26. Germany IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific IV and Oral Iron Drugs Market Share by Region (2019-2030)

Figure 34. China IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America IV and Oral Iron Drugs Market Share by Country (2019-2030)

Figure 42. Mexico IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa IV and Oral Iron Drugs Market Share by Country (2019-2030)

Figure 46. Turkey IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Daiichi Sankyo Company Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 49. Vifor Pharma Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 50. Akebia Therapeutics Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 51. Allergan Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 52. AMAG Pharmaceuticals Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 53. AOP Orphan Pharmaceuticals Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 54. Pharmacosmos Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 55. Sanofi Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 56. Shield Therapeutics Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 57. AZAD Pharma Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 58. Cirondrugs Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 59. MEDICE Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 60. Pfizer Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 61. Salveo Lifecare Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 62. Sunny Pharmaceutical Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Endoparasiticide Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36H8345

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34R905

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2R9930

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34L14446

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions